The panel will discuss their experience using A.I. in Colonoscopy to detect adenomas. The discussion will center around improvements in practice, by the comparison of ADR using A.I. versus standard of care.
The GI Genius™ intelligent endoscopy module offers a transformative solution — powered by AI — to address the challenges of detecting colorectal cancer, early.
The GI Genius™ module is designed to seamlessly integrate with your existing colonoscopy equipment and workflow. It works in real-time, automatically identifying and marking abnormalities consistent with colorectal polyps, including those with flat (non-polypoid) morphology.
Drop by for a cup of coffee and learn more about artificial intelligence in colonoscopy.
Visit us at BOOTH #027 and experience GI GeniusTM through Virtual Reality and 360 video.
Tuesday, 22/10, 09:30-11:00 & 14:00-15:30
Wednesday 23/10, 09:30-11:00
We are delighted to invite you to join our Hands-On open sessions focusing on Dysplastic Barrett's Esophagus management, using Medtronic RFA BarrxTM Catheters and Capnography Monitoring
No pre-registration required. Please walk-in the ESGE learning center to participate.
Find more about ARCHIMEDESTM during UEG Week at our Booth #027
Measure pressure and dimensions in the esophagus, pylorus, and anal sphincters with a patient-friendly solution.
The Endoflip™ impedance planimetry system transforms the way you evaluate symptoms consistent with motility disorders and helps you minimize patient discomfort.1,2,3
This advanced imaging technology provides an internal view of the gastroesophageal (GE) junction during endoscopic and surgical procedures.
Real-time measurements of the pressure and dimensions in the esophagus, and other sphincters of the alimentary canal, help you identify major motility disorders.
The digestive category has the second highest level of new cancer cases — and the second highest number of deaths. We’re committed to caring for the large, diverse population of GI patients with products to support them across the continuum of care.
Only 12.5% of Barrett’s esophagus is diagnosed4
In 5% of cases, the source of GI bleeding is not found on an upper and lower endoscopy5,6
About two million people may be affected globally7
About 65,000 deaths due to pancreatic cancer and malignant liver diseases8,9
1. Gyawali CP, Bredenoord AJ, Conklin JL, Fox M, Pandolfino JE, Peters JH, Roman S, Staiano A, Vaezi MF. Evaluation of esophageal motor function in clinical Practice. Neurogastroenterol Motil 2013;25(2):99-133.
2. Carlson DA, Lin Z, Kahrilas PJ, Sternbach J, Donnan EN, Friesen L, Listernick Z, Mogni B, Pandolfino JE. The Functional Lumen Imaging Probe Detects Esophageal Contractility Not Observed With Manometry in Patients With Achalasia. Gastroenterology 2015;149(7):1742-1751.
3. Carlson DA, Kahrilas PJ, Lin Z, Hirano I, Gonsalves N, Listernick Z, Ritter K, Tye M, Ponds FA, Wong I, Pandolfino JE. Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe. Am J Gastroenterol 2016;111(12):1726-1735.
4. Dymedex Market Development Consulting, Strategic Market Assessment: Barrx-GI, October 30, 2014.
5. Gerson L, Fidler J, Cave D, Leighton J. ACG Clinical Guideline: Diagnosis and management of small bowel bleeding. American Journal of Gastroenterology. 2015;110:1265-1287.
6. Gralnek IM. Obscure-overt gastrointestinal bleeding. Gastroenterology. 2005;128:1424-30.
7. Kaplan G. The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology. 2015;12:720-727.
8. SEER Cancer Statistics Factsheets: Pancreas Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/pancreas.html
9. Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology. 2015;149(7):1731–1741.